Please try another search
NRGene Technologies Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 2 million compared to USD 3.16 million a year ago. Net loss was USD 5.24 million compared to USD 6.21 million a year ago. Basic loss per share from continuing operations was USD 0.42 compared to USD 0.5 a year ago. Diluted loss per share from continuing operations was USD 0.42 compared to USD 0.5 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 0.426 | 0.426 | 0.574 | 0.574 |
Gross Profit | 0.224 | 0.224 | 0.227 | 0.227 |
Operating Income | -1.04 | -1.04 | -1.3 | -1.3 |
Net Income | -1.31 | -1.31 | -1.31 | -1.31 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 10.79 | 10.79 | 13.72 | 13.72 |
Total Liabilities | 3.57 | 3.57 | 3.95 | 3.95 |
Total Equity | 7.21 | 7.21 | 9.77 | 9.77 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -0.908 | -0.908 | -1.05 | -1.05 |
Cash From Investing Activities | -0.31 | -0.31 | -0.327 | -0.327 |
Cash From Financing Activities | -0.109 | -0.109 | -0.096 | -0.096 |
Net Change in Cash | -1.26 | -1.26 | -1.65 | -1.65 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review